What if the IRB required inclusion of non-English speaking participants into clinical trials, using either the Short Form process or a Fully Translated Consent; exclusion of non-English speaking individuals would not be allowed?

1. What do you perceive are the benefits to this change?
2. What do you perceive are the barriers to this change?
3. Are there certain types of studies where it would be easier to make this change?
4. Are there certain types of studies where this requirement would be inappropriate?
5. Would you, your study team, or your department require or prefer additional training on simplifying consent language?
6. Are there any additional resources you would prefer in order to make this change?

     View recored event   

Faciliator: